CytoMed Therapeutics (GDTC) Non-Interest Income (2023 - 2025)
CytoMed Therapeutics' (GDTC) quarterly Non-Interest Income came in at $30026.0 in Q2 2025, down 33.63% year-over-year from $45237.0 in Q2 2024, and down 33.63% quarter-over-quarter from $45237.0 in Q2 2024.
Powered by 
Analysis
CytoMed Therapeutics (GDTC) Non-Interest Income (2023 - 2025) Analysis & Trends
CytoMed Therapeutics has disclosed Non-Interest Income across 3 years of filings, most recently posting $30026.0 for Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Interest Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - | - |
| 7 | Precigen | 2.40 Bn | 2.40 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.36 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | CytoMed Therapeutics | 9.43 Mn | 7.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 30,026.00 |
| Jun 30, 2024 | 45,237.00 |
| Jun 30, 2023 | 30,999.00 |